https://www.cnbc.com/2017/10/30/mer...irms-downgrade-on-cancer-drug-withdrawal.html
What do we think this means for Viraytics. Opportunity or a problem?
Keytruda and Merck article about problems with lung cancer trial.
Add to My Watchlist
What is My Watchlist?